blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2239257

EP2239257 - NOVEL QUINAZOLINE-2,4-DIONE DERIVATIVE, AND MEDICAL COMPOSITIONS FOR THE PROPHYLAXIS AND TREATMENT OF CRANIAL NERVE DISEASE CONTAINING THE SAME [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.04.2013
Database last updated on 08.04.2026
Most recent event   Tooltip03.07.2015Lapse of the patent in a contracting state
New state(s): MK		published on 05.08.2015  [2015/32]
Applicant(s)For all designated states
Shin Poong Pharmaceutical Co. Ltd.
434-4 Moknae-dong Ansan-shi
Gyeonggi-do 425-100 / KR
[2010/41]
Inventor(s)01 / CHO, Il Hwan
5-1101 Seonkyeong Apt.
Seongpo-dong
Sangrok-gu
Ansan-city Gyeonggi-do 426-767 / KR
02 / LEE, Eun Bang
B-1007 Samik Apt.
51 Youido-dong
Youngdeungpo-gu
Seoul 150-894 / KR
03 / KANG, Sin Cheol
205 Geonyang Apt. 1st
Daeyami-dong
Gunpo-city Gyeonggi-do 435-060 / KR
04 / KIM, Won Seok
1215-401, Ecometro Apt.,
Nonhyeon-dong
Namdong-gu Incheon 405-794 / KR
05 / LEE, Chul Kyu
206-505 Taeyoung Apt.
Bonoh 3-dong
Sangrok-gu
Ansan-city Gyeonggi-do 426-735 / KR
 [2012/23]
Former [2010/50]01 / CHO, Il Hwan
5-1101 Seonkyeong Apt. Seongpo-dong Sangrok-gu
Ansan-city Gyeonggi-do 426-767 / KR
02 / LEE, Eun Bang
B-1007 Samik Apt. 51 Youido-dong Youngdeungpo-gu
Seoul 150-894 / KR
03 / KANG, Sin Cheol
205 Geonyang Apt. 1st Daeyami-dong
Gunpo-city Gyeonggi-do 435-060 / KR
04 / KIM, Won Seok
1215-401, Ecometro Apt., Nonhyeon-dong
Namdong-gu Incheon 405-794 / KR
05 / LEE, Chul Kyu
206-505 Taeyoung Apt. Bonoh 3-dong Sangrok-gu
Ansan-city Gyeonggi-do 426-735 / KR
Former [2010/41]01 / CHO, Il Hwan
5-1101 Seonkyeong Apt. Seongpo-dong Sangrok-gu
Ansan-city Gyeonggi-do 426-767 / KR
02 / LEE, Eun Bang
B-1007 Samik Apt. 51 Youido-dong Youngdeungpo-gu
Seoul 150-894 / KR
03 / KANG, Sin Cheol
205 Geonyang Apt. 1st Daeyami-dong
Gunpo-city Gyeonggi-do 435-060 / KR
04 / KIM, Won Seok
105-403 Samhwan Hanjin Apt. Janggok-dong
Siheung-city Gyeonggi-do 429-735 / KR
05 / LEE, Chul Kyu
206-505 Taeyoung Apt. Bonoh 3-dong Sangrok-gu
Ansan-city Gyeonggi-do 426-735 / KR
Representative(s)Arth, Hans-Lothar, et al
ABK Patent & Trademark Attorneys
Jasminweg 9
14052 Berlin / DE
[2012/23]
Former [2010/41]Arth, Hans-Lothar, et al
ABK Patent & Trademark Attorneys Jasminweg 9
D-14052 Berlin / DE
Application number, filing date09705187.408.01.2009
[2010/41]
WO2009KR00083
Priority number, dateKR2008000939030.01.2008         Original published format: KR 20080009390
[2010/41]
Filing languageKO
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009096667
Date:06.08.2009
Language:KO
[2009/32]
Type: A2 Application without search report 
No.:EP2239257
Date:13.10.2010
Language:EN
[2010/41]
Type: B1 Patent specification 
No.:EP2239257
Date:06.06.2012
Language:EN
[2012/23]
Search report(s)International search report - published on:KR08.10.2009
(Supplementary) European search report - dispatched on:EP20.05.2011
ClassificationIPC:C07D239/96
[2010/41]
CPC:
C07D403/12 (EP,US); C07D239/96 (EP,KR,US); A61K31/517 (KR);
A61P25/00 (EP); A61P25/02 (EP); A61P25/08 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/18 (EP);
A61P25/28 (EP); A61P9/00 (EP); A61P9/10 (EP) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/41]
TitleGerman:NEUES CHINAZOLIN-2,4-DION-DERIVAT UND MEDIZINISCHE ZUSAMMENSETZUNGEN ZUR PROPHYLAXE UND BEHANDLUNG VON KRANIALER NERVENKRANKHEIT DAMIT[2010/41]
English:NOVEL QUINAZOLINE-2,4-DIONE DERIVATIVE, AND MEDICAL COMPOSITIONS FOR THE PROPHYLAXIS AND TREATMENT OF CRANIAL NERVE DISEASE CONTAINING THE SAME[2010/41]
French:NOUVEAU DÉRIVÉ DE QUINAZOLINE-2,4-DIONE ET COMPOSITIONS MÉDICALES POUR LA PROPHYLAXIE ET LE TRAITEMENT DE LA MALADIE DU NERF CRÂNIEN CONTENANT LEDIT DÉRIVÉ[2010/41]
Entry into regional phase28.07.2010Translation filed 
28.07.2010National basic fee paid 
28.07.2010Search fee paid 
28.07.2010Designation fee(s) paid 
28.07.2010Examination fee paid 
Examination procedure21.08.2009Request for preliminary examination filed
International Preliminary Examining Authority: KR
28.07.2010Amendment by applicant (claims and/or description)
28.07.2010Examination requested  [2010/41]
03.02.2012Communication of intention to grant the patent
16.04.2012Fee for grant paid
16.04.2012Fee for publishing/printing paid
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  03.02.2012
Opposition(s)07.03.2013No opposition filed within time limit [2013/20]
Fees paidRenewal fee
13.12.2010Renewal fee patent year 03
06.12.2011Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY06.06.2012
EE06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
MK06.06.2012
MT06.06.2012
SI06.06.2012
IS06.10.2012
MC31.01.2013
[2015/32]
Former [2014/32]CY06.06.2012
EE06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
MT06.06.2012
SI06.06.2012
IS06.10.2012
MC31.01.2013
Former [2013/37]CY06.06.2012
EE06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
SI06.06.2012
IS06.10.2012
MC31.01.2013
Former [2013/10]CY06.06.2012
EE06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
SI06.06.2012
IS06.10.2012
Former [2013/09]CY06.06.2012
EE06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
SI06.06.2012
Former [2012/51]CY06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
SI06.06.2012
Former [2012/50]CY06.06.2012
HR06.06.2012
LT06.06.2012
LV06.06.2012
Former [2012/49]CY06.06.2012
LT06.06.2012
Former [2012/47]LT06.06.2012
Documents cited:Search[A] WO02083651  (UNIV KINGSTON et al.) [A] 1-15 * page 3, line 5 - line 25 * * claim 1 *
 [A] WO9519346  (SANDOZ LTD et al.) [A] 1-15 * claims 1,6-9 *
 [A] WO03059892  (BAYER AG et al.) [A] 1-15 * page 17, line 28 - line 29 * * claim 1 *
by applicant  NAGASAWA, H.; GOGURE, K., STROKE, vol. 20, 1989, pages 1037 - 1043
   CHOI, D. W., NEUROSCI. LETT., vol. 58, 1985, pages 293 - 297
   ALI, A. ET AL., PHARMACOLOGICAL REPORTS, vol. 58, 2006, pages 242 - 245
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.